HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

[Secondary prevention of myocardial infarct].

Abstract
Preventive measures are the most powerful measures to treat manifestations of ischemic cardiopathy. Secondary prevention of myocardial infarction involves the following intervention areas: a) Limitation of adverse physiological and emotional consequences of the acute illness; b) Identification of the patients particularly exposed to the risk of new episodes of ischemic cardiopathy or to their consequences, namely reinfarction and sudden death; c) Institution of therapeutic attitudes, surgical or medical, that can prolong life and can oppose functional deterioration and prevent symptoms; d) Institution of measures that can oppose the progression of the initial disease that is, in almost all cases, atherosclerosis. Measures that can oppose the progression of cardiac disease and its consequences after an episode of myocardial infarction, and measures that can oppose the evolution of atherosclerosis are described in this article. The measures that can influence the risk factors after an episode of myocardial infarction are briefly commented: characteristics related to life style and physical exercise; smoking habits; plasmatic lipid levels; high blood pressure; and therapeutic substitution with estrogens after menopause. Pharmacological interventions in secondary prevention of myocardial infarction are described, namely with the following groups of substances: beta-adrenergic blocking agents; platelet active agents; anticoagulants; and angiotensin-converting enzyme inhibitors.
AuthorsA L Santos
JournalActa meĢdica portuguesa (Acta Med Port) Vol. 11 Issue 5 Pg. 483-91 (May 1998) ISSN: 0870-399X [Print] PORTUGAL
Vernacular TitlePrevenção secundária do enfarte do miocárdio.
PMID9951059 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Anticoagulants
  • Estrogens
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Angiotensin-Converting Enzyme Inhibitors (therapeutic use)
  • Anticoagulants (therapeutic use)
  • Estrogens (blood)
  • Exercise
  • Humans
  • Hypercholesterolemia (therapy)
  • Hypertension (therapy)
  • Life Style
  • Myocardial Infarction (prevention & control)
  • Risk Factors
  • Smoking (prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: